Earth Science Tech Inc (ETST) Return on Assets ROA from the first quarter of 2026 to first quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Earth Science Tech Inc   (ETST)


Earth Science Tech Inc 's ROA from the first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Earth Science Tech Inc 's ROA in the first quarter of 2026?
Earth Science Tech Inc achieved a return on average assets (ROA) of 44.47 % in its first quarter of 2026, which is below Earth Science Tech Inc 's average return on assets, which stands at 172.46%.

ROA decreased relative to the period ending Mar 31 2026, due to the decline in net income.

However, within the Healthcare sector 15 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the fourth quarter of 2026 from 86 to 101.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter
Y / Y Total Assets Change 37.34 % 30.1 % 85.09 % 75.67 % 58.28 %
Y / Y Net Income Change 51.19 % 9.84 % 341.05 % 18.48 % -56.02 %
Net Income (TTM) in million 4 4 4 3 3
Return On Assets (TTM) 44.47 % 45.36 % 46.97 % 41.99 % 46.09 %
ETST's Total Ranking # 101 # 86 # 75 # 97 # 88
Total Assets (TTM) in million 10 9 7 8 8
Seq. Total Assets Change 15.66 % 30.1 % -18.74 % 12.33 % 9.56 %
Seq. Net Income Change -44.43 % 41.48 % -3.76 % 99.82 % -59.63 %

ETST's 5 Years Annual ROA >> Back to ETST Management Effectiveness >> Compare ETST ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 9
Sector # 16
Overall # 85

Return On Assets Statistics
High Average Low
5423.7 %
172.46 %
-3585.66 %
(Mar 31 2022)   (Mar 31 2021)





Financial Statements
Earth Science Tech Inc 's Assets $ 10 million ETST's Balance sheet
Earth Science Tech Inc 's Income $ 1 million Quarterly ETST's Income Statement
ETST's Income by Division See ETST's Income by Division



Annual Return On Assets (Mar 31 2026)
FY 2026		 (Mar 31 2025)
FY 2025		 (Mar 31 2024)
FY 2024		 (Mar 31 2023)
FY 2023		 (Mar 31 2022)
FY 2022
Y / Y Total Assets Change 30.1 % 85.09 % 47.38 % 4761.71 % 0.13 %
Total Assets in million 9 7 4 3 0
Y / Y Net Income Change 10.67 % 300.63 % - - -
Net Income in million 4 3 1 0 3
Annual Return On Assets 40.15 % 47.19 % 21.8 % -14.46 % 6104.3 %

ETST's 5 Years Annual ROA >> Back to ETST Management Effectiveness >> Compare ETST ROA to its Competitors



Comment on ETST's ROA in the fiscal year ending 2026
In the fiscal year 2026 ROA deteriorated to 40.15 %, despite annual net income growth of 10.67 % to $3.60 million, from $3.25 million a year ago, as ETST's assets increase to $8.97 million, by 10.67 %.


More Return On Assets Ratios
ETST's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ETST's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ETST's Competitors
Subscribers only: Roa for Earth Science Tech Inc 's Suppliers
Subscribers only: Return On Assets for ETST's Customers

You may also want to know
ETST's Roi ETST's Inventory Turnover Ratio ETST's Growth Rates ETST's Dividend Comparisons
ETST's Profitability Ratios ETST's Asset Turnover Ratio ETST's Dividend Growth
ETST's Roe ETST's Valuation Ratios ETST's Financial Strength Ratios ETST's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Elutia Inc   108.72 %
Silexion Therapeutics Corp  99.09 %
Arbutus Biopharma Corp  96.04 %
Pulmatrix Inc   94.81 %
Quince Therapeutics Inc   88.46 %
Interpace Biosciences Inc   85.91 %
Oncotelic Therapeutics Inc   81.75 %
Rigel Pharmaceuticals Inc  72.27 %
Actinium Pharmaceuticals Inc  71.73 %
Sanuwave Health Inc   71.60 %
Exelixis Inc   70.51 %
Rallybio Corporation  64.51 %
Oramed Pharmaceuticals Inc  64.18 %
Fortress Biotech Inc   60.88 %
Atlantic Coastal Acquisition Corp Ii  54.09 %
Lensar Inc   47.48 %
Elite Pharmaceuticals Inc   46.11 %
Omeros Corporation  46.05 %
Q32 Bio Inc   45.18 %
Aurinia Pharmaceuticals Inc   44.95 %
Agenus Inc  44.86 %
Earth Science Tech Inc   44.02 %
Liquidia Corporation  36.30 %
Ironwood Pharmaceuticals inc   34.34 %
Idexx Laboratories Inc  33.61 %
Tg Therapeutics Inc   33.59 %
Meiragtx Holdings Plc  29.37 %
Indivior Pharmaceuticals Inc   28.21 %
Qhslab Inc   27.12 %
Adma Biologics Inc   26.58 %

Date modified: 2026-09-26T07:27:16+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.